Politico December 24, 2025
Sophie Gardner, Kelly Hooper

Driving the Day

‘LIKE A TIME BOMB’ — The federal government wants to make it easier for Medicaid patients to access new, curative treatments — one of the few initiatives on which President Donald Trump and the public health establishment are aligned, Kelly reports.

Gene therapy treatments for sickle cell disease, a hereditary condition that has meant a lifetime of excruciating pain and debilitating health issues for tens of thousands of Black Americans, were first approved by the FDA about two years ago. But it doesn’t mean people desperate for a cure will be able to access gene therapy anytime soon.

“There’s a need for pretty sophisticated clinical infrastructure that doesn’t exist in every state,” said Jack Rollins, director of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Medicaid, Provider
Infographic: 3 Social Media Tips for CNOs
What Home-Based Care Consumers Really Want
The 250 best hospitals, according to Healthgrades
STAT+: 9 influencers shaping health information online, for better or worse
Doctors Increasingly See AI Scribes in a Positive Light. But Hiccups Persist.

Share Article